The Department of Health and Human Services on Friday approved the use of OraSure Technologies' rapid HIV test in about 180,000 nonlaboratory sites, including doctors' offices, clinics, and HIV outreach organizations. The OraQuick Rapid HIV-1/2 test produces results in about 20 minutes from either blood from a finger stick or from oral fluids collected on a special swab. The test is expected to be widely available by mid August, according to OraSure officials. In related news, HHS secretary Tommy Thompson on Friday announced that the Administration is releasing $4.8 million in funding to the Substance Abuse and Mental Health Services Administration to support expanded HIV antibody testing among injection-drug users and their sex partners.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















